02137.HK

Aug 21, 2026, 00:46 UTC

Brii Biosciences reported its interim results for the six months ended June 2026, with a narrowed net loss attributable to shareholders of RMB 101 million, compared to a loss of RMB 148 million in the same period last year, and no interim dividend declared.